Targeted Ablation of Osteocytes Induces Osteoporosis with Defective Mechanotransduction

Cell Metabolism

Volumn 5, Issue 6, 2007, Pages 464-475

  Tatsumi, Sawako ^a,b   Ishii, Kiyoaki ^a   Amizuka, Norio ^c   Li, Minqi ^c   Kobayashi, Toshihiro ^a   Kohno, Kenji ^d   Ito, Masako ^e   Takeshita, Sunao ^a   Ikeda, Kyoji ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^e NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HUMDISEASE

Indexed keywords

DIPHTHERIA TOXIN; RECEPTOR;

ADIPOSE TISSUE; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE FRAGILITY; BONE MARROW; BONE REMODELING; BONE STRUCTURE; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; CORTICAL BONE; DRUG TARGETING; FRACTURE; IN VIVO STUDY; MECHANOTRANSDUCTION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; POROSITY; PRIORITY JOURNAL; TRABECULAR BONE; TRANSGENIC MOUSE;

ADIPOSE TISSUE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MECHANOTRANSDUCTION, CELLULAR; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOCYTES; OSTEOPOROSIS; OSTEOPROTEGERIN; RANK LIGAND; STRESS, MECHANICAL;

MUS; MUS MUSCULUS;

EID: 34249657953     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.05.001     Document Type: Article

References (47)

1. Aarden E.M., Burger E.H., and Nijweide P.J. Function of osteocytes in bone. J. Cell. Biochem. 55 (1994) 287-299
2. Amizuka N., Kwan M.Y., Goltzman D., Ozawa H., and White J.H. Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage. J. Clin. Invest. 103 (1999) 373-381
3. Bikle D.D., and Halloran B.P. The response of bone to unloading. J. Bone Miner. Metab. 17 (1999) 233-244
4. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
5. Brodt M.D., Ellis C.B., and Silva M.J. Growing C57Bl/6 mice increase whole bone mechanical properties by increasing geometric and material properties. J. Bone Miner. Res. 14 (1999) 2159-2166
6. Burger E.H., and Klein-Nulend J. Mechanotransduction in bone--role of the lacuno-canalicular network. FASEB J. 13 Suppl (1999) S101-S112
7. Ducy P., Schinke T., and Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 289 (2000) 1501-1504
8. Ehrlich P.J., and Lanyon L.E. Mechanical strain and bone cell function: a review. Osteoporos. Int. 13 (2002) 688-700
9. Feng J.Q., Ward L.M., Liu S., Lu Y., Xie Y., Yuan B., Yu X., Rauch F., Davis S.I., Zhang S., et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 38 (2006) 1310-1315
10. Franz-Odendaal T.A., Hall B.K., and Witten P.E. Buried alive: how osteoblasts become osteocytes. Dev. Dyn. 235 (2006) 176-190
11. George A., Sabsay B., Simonian P.A., and Veis A. Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization. J. Biol. Chem. 268 (1993) 12624-12630
12. Globus R.K., Bikle D.D., and Morey-Holton E. Effects of simulated weightlessness on bone mineral metabolism. Endocrinology 114 (1984) 2264-2270
13. Harada S., and Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 423 (2003) 349-355
14. Ito M., Ikeda K., Nishiguchi M., Shindo H., Uetani M., Hosoi T., and Orimo H. Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk. J. Bone Miner. Res. 20 (2005) 1828-1836
15. Kalajzic I., Braut A., Guo D., Jiang X., Kronenberg M.S., Mina M., Harris M.A., Harris S.E., and Rowe D.W. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 35 (2004) 74-82
16. Kamioka H., Honjo T., and Takano-Yamamoto T. A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy. Bone 28 (2001) 145-149
17. Karsenty G., and Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2 (2002) 389-406
18. Kato Y., Windle J.J., Koop B.A., Mundy G.R., and Bonewald L.F. Establishment of an osteocyte-like cell line, MLO-Y4. J. Bone Miner. Res. 12 (1997) 2014-2023
19. Li X., Zhang Y., Kang H., Liu W., Liu P., Zhang J., Harris S.E., and Wu D. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280 (2005) 19883-19887
20. Ling Y., Rios H.F., Myers E.R., Lu Y., Feng J.Q., and Boskey A.L. DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J. Bone Miner. Res. 20 (2005) 2169-2177
21. Liu S., Zhou J., Tang W., Jiang X., Rowe D.W., and Quarles L.D. Pathogenic role of Fgf23 in Hyp mice. Am. J. Physiol. Endocrinol. Metab. 291 (2006) E38-E49
22. Manolagas S.C., and Jilka R.L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332 (1995) 305-311
23. Martin T.J., and Sims N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11 (2005) 76-81
24. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., and de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108 (2002) 17-29
25. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res. 11 (1996) 1043-1051
26. Parfitt A.M. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J. Cell. Biochem. 55 (1994) 273-286
27. Parfitt A.M. Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30 (2002) 5-7
28. Poole K.E., van Bezooijen R.L., Loveridge N., Hamersma H., Papapoulos S.E., Lowik C.W., and Reeve J. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 19 (2005) 1842-1844
29. Qiu S., Rao D.S., Palnitkar S., and Parfitt A.M. Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone. Bone 31 (2002) 313-318
30. Raisz L.G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115 (2005) 3318-3325
31. Riggs B.L., and Melton III L.J. Involutional osteoporosis. N. Engl. J. Med. 314 (1986) 1676-1686
32. Saito M., Iwawaki T., Taya C., Yonekawa H., Noda M., Inui Y., Mekada E., Kimata Y., Tsuru A., and Kohno K. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 19 (2001) 746-750
33. Sambrook P., and Cooper C. Osteoporosis. Lancet 367 (2006) 2010-2018
34. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 359 (2002) 1841-1850
35. Seeman E., and Delmas P.D. Bone quality--the material and structural basis of bone strength and fragility. N. Engl. J. Med. 354 (2006) 2250-2261
36. Sessions N.D., Halloran B.P., Bikle D.D., Wronski T.J., Cone C.M., and Morey-Holton E. Bone response to normal weight bearing after a period of skeletal unloading. Am. J. Physiol. 257 (1989) E606-E610
37. Shimada T., Kakitani M., Yamazaki Y., Hasegawa H., Takeuchi Y., Fujita T., Fukumoto S., Tomizuka K., and Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113 (2004) 561-568
38. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., Takaoka A., Yokochi T., Oda H., Tanaka K., et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408 (2000) 600-605
39. Takeshita S., Namba N., Zhao J.J., Jiang Y., Genant H.K., Silva M.J., Brodt M.D., Helgason C.D., Kalesnikoff J., Rauh M.J., et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8 (2002) 943-949
40. Teitelbaum S.L., and Ross F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4 (2003) 638-649
41. Tomkinson A., Reeve J., Shaw R.W., and Noble B.S. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J. Clin. Endocrinol. Metab. 82 (1997) 3128-3135
42. Toyosawa S., Shintani S., Fujiwara T., Ooshima T., Sato A., Ijuhin N., and Komori T. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J. Bone Miner. Res. 16 (2001) 2017-2026
43. van Bezooijen R.L., Roelen B.A., Visser A., van der Wee-Pals L., de Wilt E., Karperien M., Hamersma H., Papapoulos S.E., ten Dijke P., and Lowik C.W. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199 (2004) 805-814
44. Weinstein R.S., Nicholas R.W., and Manolagas S.C. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J. Clin. Endocrinol. Metab. 85 (2000) 2907-2912
45. Winkler D.G., Sutherland M.K., Geoghegan J.C., Yu C., Hayes T., Skonier J.E., Shpektor D., Jonas M., Kovacevich B.R., Staehling-Hampton K., et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 22 (2003) 6267-6276
46. Yang W., Lu Y., Kalajzic I., Guo D., Harris M.A., Gluhak-Heinrich J., Kotha S., Bonewald L.F., Feng J.Q., Rowe D.W., et al. Dentin matrix protein 1 gene cis-regulation: use in osteocytes to characterize local responses to mechanical loading in vitro and in vivo. J. Biol. Chem. 280 (2005) 20680-20690
47. Ye L., Mishina Y., Chen D., Huang H., Dallas S.L., Dallas M.R., Sivakumar P., Kunieda T., Tsutsui T.W., Boskey A., et al. Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype. J. Biol. Chem. 280 (2005) 6197-6203